SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-043497
Filing Date
2013-08-07
Accepted
2013-08-07 10:33:26
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v350675_10q.htm 10-Q 710580
2 EXHIBIT 31.1 v350675_ex31-1.htm EX-31.1 7959
3 EXHIBIT 31.2 v350675_ex31-2.htm EX-31.2 7724
4 EXHIBIT 32.1 v350675_ex32-1.htm EX-32.1 4116
5 EXHIBIT 32.2 v350675_ex32-2.htm EX-32.2 4178
  Complete submission text file 0001144204-13-043497.txt   3324642

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rprx-20130630.xml EX-101.INS 200245
7 XBRL TAXONOMY EXTENSION SCHEMA rprx-20130630.xsd EX-101.SCH 25082
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rprx-20130630_cal.xml EX-101.CAL 30422
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rprx-20130630_def.xml EX-101.DEF 117743
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20130630_lab.xml EX-101.LAB 169207
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20130630_pre.xml EX-101.PRE 139597
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 131016209
SIC: 2836 Biological Products, (No Diagnostic Substances)